Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Regulatorymenopausegray marketbpc-157fda

Gynecologists say menopause peptide marketing outruns the evidence

Clinicians interviewed by Everyday Health flag gray-market injectables labeled "research chemicals" and sourced abroad as the central safety problem.

DO
By Daniel Okafor · Regulatory Correspondent
Oct 2 15:25 ETSource: Everyday Health

The wire

  1. 01Robin Noble, MD, chief medical adviser for Let's Talk Menopause, says there is no good data showing peptides help menopause symptoms, and none are FDA-approved for bone, muscle, collagen or skin changes.
  2. 02Maven Clinic's Stacey Silverman Fine, MD, distinguishes approved provider-prescribed peptides from anti-aging, recovery and performance products she calls unproven, unregulated and of unestablished safety.
  3. 03Noble says many gray-market products are manufactured in China or India without rigorous quality control, and that dose, frequency and candidate selection are all unknown.

From the source

Peptide Therapy for Menopause: What You Need to Know

Is peptide therapy really a revolutionary cure-all for menopause symptoms ? "There hasn't been any good data that peptides are helpful," says Robin Noble, MD , a gynecologist in Portland, Maine, and the chief medical adviser for Let's Talk Menopause , a nonprofit organization focused on advocacy and education for women going through menopause.

Read at everydayhealth.com
PeptiPrescribed peptides from $99/moSee all →